首页> 美国卫生研究院文献>Balkan Journal of Medical Genetics : BJMG >Translocation t(3;12)(q26;q21) in JAK2V617F Point Mutation Negative Chronic Idiopathic Myelofibrosis: A Case Report
【2h】

Translocation t(3;12)(q26;q21) in JAK2V617F Point Mutation Negative Chronic Idiopathic Myelofibrosis: A Case Report

机译:JAK2V617F点突变阴性慢性特发性骨髓纤维化易位t(3; 12)(q26; q21):一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The myeloproliferative diseases (MPDs) or myelo-proliferative neoplasms (MPNs) are a group of diseases of the bone marrow in which excess cells are produced. Chronic idiopathic myelofibrosis (CIMF) is a stem cell defect characterized by splenomegaly with multiorgan extramedullary hematopoiesis, immature peripheral blood granulocytes and erythrocytes and progressive bone marrow fibrosis. The most common chromosomal abnormalities seen in CIMF patients include numerical changes of chromosomes 7, 8 and 9, and structural changes of 1q, 5q, 13q and 20q. At least 75.0% of patients with bone marrow abnormalities have one or more of these chromosomal anomalies. Detection of the Janus kinase 2 (JAK2) mutation may be a potential major breakthrough for understanding the pathobiology of MPNs, and is an essential part of the diagnostic algorithm. In this study, we describe a JAK2V617F mutation negative CIMF patient who has the chromosomal translocation t(3;12)(q26;q21) in her karyotype.
机译:骨髓增生性疾病(MPD)或骨髓增生性肿瘤(MPN)是一组骨髓疾病,其中会产生过量的细胞。慢性特发性骨髓纤维化(CIMF)是一种干细胞缺陷,其特征是脾肿大,伴有多器官髓外造血,未成熟的外周血粒细胞和红细胞以及进行性骨髓纤维化。 CIMF患者中最常见的染色体异常包括染色体7、8和9的数值变化,以及1q,5q,13q和20q的结构变化。至少75.0%的骨髓异常患者患有一种或多种这些染色体异常。 Janus激酶2(JAK2)突变的检测可能是理解MPN病理生物学的潜在重大突破,并且是诊断算法的重要组成部分。在这项研究中,我们描述了一个JAK2 V617F 突变阴性CIMF患者,其染色体核型为t(3; 12)(q26; q21)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号